Hikma Delivers On Authorized Xyrem In US

Also Strikes Deal With Junshi For Toripalimab In MENA Region

 
• By Dave Wallace

Hikma has begun 2023 with the long-awaited launch of a US authorized generic version of Xyrem (sodium oxybate). Meanwhile, the company has also struck a deal with Junshi Biosciences for toripalimab in the MENA region.

Rocket Launch 2023
Hikma has kicked off the year with a long-awaited launch • Source: Shutterstock

More from Products

More from Generics Bulletin